Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.4) replacing the previous (v3.6.3), indicating an update to the page's version history. This is a minor metadata update that tracks the latest revision of the record.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record history now includes a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry. This updates the version history to reflect the latest release label.SummaryDifference0.1%

- Check35 days agoChange DetectedA new latest revision, v3.6.2, is added to the history and the previous v3.6.0 entry is removed, indicating a minor backend update to the page’s record-keeping.SummaryDifference0.1%

- Check49 days agoChange DetectedRecruitment status updated to 'No longer looking for participants.' The record revision advanced to v3.6.0, replacing the previous v3.5.5 revision.SummaryDifference0.3%

- Check56 days agoChange DetectedThe history entry is updated to v3.5.5, replacing the previous v3.5.4, representing a minor software/UI update to the page rather than substantive content changes.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page history revision was updated from v3.5.3 to v3.5.4. This reflects a small update to the record's version history and does not modify the page content or its associated data.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.